Case filing & court posture: Azzur Group Holdings LLC and 35 affiliated debtors filed chapter 11 on March 2, 2025 in the United States Bankruptcy Court for the District of Delaware (Case No. 25-10342, Judge Karen B. Owens presiding). Dkt. 1 The debtors provided GxP compliance solutions for the biotechnology and pharmaceutical industries through three business lines: Azzur Consulting, Azzur Labs, and Cleanrooms on Demand.
Liquidity & financing path: The debtors secured up to $23.5 million in debtor-in-possession financing from M&T Bank, with an interim DIP order entered on March 4, 2025. Dkt. 61 The DIP facility provided liquidity to fund operations and the sale process during the restructuring.
Restructuring outcome: The debtors pursued asset sales as their exit strategy, with bidding procedures approved on March 28, 2025. Dkt. 177 The Consulting business was sold to Eliquent Life Sciences for $56 million plus assumed liabilities in May 2025, and the Cleanrooms on Demand business sold for $600,000. A joint chapter 11 plan was confirmed on October 3, 2025. Dkt. 735
Plan effective date & post-confirmation: The confirmed plan became effective on October 21, 2025, providing M&T Bank approximately 63% recovery and general unsecured creditors approximately 2.1% recovery from a $1.625 million settlement pool. A plan administrator was appointed to oversee wind-down and distributions.
Current status: The case remains open in wind-down administration, with ongoing professional fee applications and final distributions to creditors being processed as of December 2025.
